Comparison between of the attenuated BR-Oka and the wild type strain of varicella zoster virus (VZV) on the DNA level
- Authors
- Lim, SM; Song, SW; Kim, SL; Jang, YJ; Kim, KH; Kim, HJ
- Issue Date
- Aug-2000
- Publisher
- PHARMACEUTICAL SOCIETY KOREA
- Keywords
- VZV; Oka; chicken pox; vaccine
- Citation
- ARCHIVES OF PHARMACAL RESEARCH, v.23, no.4, pp 418 - 423
- Pages
- 6
- Journal Title
- ARCHIVES OF PHARMACAL RESEARCH
- Volume
- 23
- Number
- 4
- Start Page
- 418
- End Page
- 423
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/25304
- DOI
- 10.1007/BF02975458
- ISSN
- 0253-6269
- Abstract
- Oka strain VR-795 (Varicella Zoster Virus, VZV) of American Type Culture Collection (ATCC) has been used for chickenpox vaccine production. In order to use this strain for vaccine production, the strain must be identified and its stability must be confirmed. The identification of the Oka strain has been confirmed using Restriction Fragment Length Polymorphism (RFLP) and DNA sequence analysis of glycoprotein-ll (gp-ll). The amino acid sequences of Oka deduced from the DNA sequence of gp-II have changed at three amino acids against Ellen and at one amino acid against Webster. To prove the stability of the Oka strain during the passage, RFLP and DNA sequence analyses were also used with 11, 15 and 23 times of virus passage. We found that the Oka strain was stable at passages of up to 23 times, based on the RFLP and DNA sequence analyses. The confirmed Oka strain was renamed as BR-Oka for the purposes of chickenpox vaccine production.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.